Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models

Journal of Controlled Release(2022)10.1016/j.jconrel.2022.11.060Source: DataRank Database

Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models is a research paper published in Journal of Controlled Release (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.65)OA: hybridTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Lenka Kotrchová ORCID,Eva Randárová ORCID,Carolina A. Ferreira ORCID,Iva Malátová,Hye Jin Lee ORCID

Live enrichment

PubMed:36470330 PMC:PMC9892306 OpenAlex:https://openalex.org/W4310980439

Ministerstvo Školství, Mládeže a Tělovýchovy

Grant: LX22NPO5102

Akademie Věd České Republiky

Grant: MSM200502104

National Institutes of Health

Grant: P30CA014520

National Institutes of Health

Grant: 5P30CA014520-18

CANCER CENTER SUPPORT

European Commission

University of Wisconsin-Madison

National Cancer Research Institute

FWCI

0.65

Citation Percentile

0.6%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://www.sciencedirect.com/science/article/pii/S0168365922008148/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S0168365922008148/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0168365922008148?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365922008148?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jconrel.2022.11.060

Fields of Study

Nanoparticle-Based Drug DeliveryGraphene and Nanomaterials ApplicationsDendrimers and Hyperbranched Polymers0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsMicePolymersDrug CarriersNanomedicineCell Line, TumorDoxorubicinDisease Models, Animal

MeSH Terms

AnimalsDisease Models, AnimalDoxorubicinDrug CarriersPolymersCell Line, TumorNanomedicineMice

Keywords

NanomedicineDoxorubicinIn vivoPharmacokineticsCancer researchDrug carrierPositron emission tomographyDistribution (mathematics)PharmacologyMaterials scienceBiomedical engineeringDrugChemistryMedicineChemotherapyNanotechnologyNuclear medicineInternal medicineBiologyNanoparticleCancerbiodistributionDrug DeliveryHpmaPolymeric CarriersDrug CarriersPolymersArticleMiceDisease Models, AnimalCell Line, TumorAnimals

Sustainable Development Goals

SDG 3: 3. Good health